Email Updates
Study
Association of adverse events in opioid addiction treatment with quality measure for continuity of pharmacotherapy.
February 16, 2022
Liu Y, Becker A, Mattke S. J Healthc Qual. 2022;44(3):e38-e43.
Medication-assisted treatment (MAT) is increasingly used to treat opioid use disorder (OUD). This study found that providers or practices with higher quality measure scores of MAT continuity (percentage of patients with OUD who had at least 180 days of continuous treatment) had a lower risk of opioid-related adverse events among their patients.
